Literature DB >> 10930171

Nelfinavir pharmacokinetics in HIV-infected children: a comparison of twice daily and three times daily dosing.

T Schuster, R Linde, U Wintergerst, M B Funk, M Kurowski, W Kreuz, D Hofmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10930171     DOI： 10.1097/00002030-200007070-00029

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  3 in total

1.  Bayesian parameter estimates of nelfinavir and its active metabolite, hydroxy-tert-butylamide, in infants perinatally infected with human immunodeficiency virus type 1.

Authors:  Salomé Payen; Albert Faye; Alexandra Compagnucci; Carlo Giaquinto; Diana Gibbs; Roberto Gomeni; Françoise Bressolle; Evelyne Jacqz-Aigrain
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

Review 2.  Pharmacokinetics of antiretroviral therapy in HIV-1-infected children.

Authors:  Pieter L A Fraaij; Jeroen J A van Kampen; David M Burger; Ronald de Groot
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

Review 3.  The role of protease inhibitor therapy in children with HIV infection.

Authors:  Patrick J Gavin; Ram Yogev
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.